|
HY-P9934-1mg
|
MedChemexpress LLC
|
Abciximab [CAS 143653-53-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P9934-10mg
|
MedChemexpress LLC
|
Abciximab [CAS 143653-53-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P9934-5mg
|
MedChemexpress LLC
|
Abciximab [CAS 143653-53-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P9928A-2mg
|
MedChemexpress LLC
|
Alirocumab (anti-PCSK9) [CAS 1245916-14-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P9928A-5mg
|
MedChemexpress LLC
|
Alirocumab (anti-PCSK9) [CAS 1245916-14-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P99105-1mg
|
MedChemexpress LLC
|
Anselamimab [CAS 2414866-63-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P99105-10mg
|
MedChemexpress LLC
|
Anselamimab [CAS 2414866-63-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P99105-5mg
|
MedChemexpress LLC
|
Anselamimab [CAS 2414866-63-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P99441-1mg
|
MedChemexpress LLC
|
Apitegromab [CAS 2278276-46-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P99441-10mg
|
MedChemexpress LLC
|
Apitegromab [CAS 2278276-46-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P99441-5mg
|
MedChemexpress LLC
|
Apitegromab [CAS 2278276-46-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1449A-10mg
|
MedChemexpress LLC
|
Boc-Gly-Gly-Phe-Gly-OH (TFA) [CAS 2450273-39-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1449A-5mg
|
MedChemexpress LLC
|
Boc-Gly-Gly-Phe-Gly-OH (TFA) [CAS 2450273-39-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P9987-1mg
|
MedChemexpress LLC
|
Crizanlizumab [CAS 1690318-25-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P9987-10mg
|
MedChemexpress LLC
|
Crizanlizumab [CAS 1690318-25-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P9987-5mg
|
MedChemexpress LLC
|
Crizanlizumab [CAS 1690318-25-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-115524-1mg
|
MedChemexpress LLC
|
DBCO-NHS ester 2 [CAS 1384870-47-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-115524-10mg
|
MedChemexpress LLC
|
DBCO-NHS ester 2 [CAS 1384870-47-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-115524-100mg
|
MedChemexpress LLC
|
DBCO-NHS ester 2 [CAS 1384870-47-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-115524-25mg
|
MedChemexpress LLC
|
DBCO-NHS ester 2 [CAS 1384870-47-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-115524-5mg
|
MedChemexpress LLC
|
DBCO-NHS ester 2 [CAS 1384870-47-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-115524-50mg
|
MedChemexpress LLC
|
DBCO-NHS ester 2 [CAS 1384870-47-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P9914-1mg
|
MedChemexpress LLC
|
Eculizumab [CAS 219685-50-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P9914-5mg
|
MedChemexpress LLC
|
Eculizumab [CAS 219685-50-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P9940-1mg
|
MedChemexpress LLC
|
Emicizumab [CAS 1610943-06-0]
|
|
Neuroscience-Neuromodulation
|
|
